Clara P W Klerk

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review
    Clara P W Klerk
    Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Arch Intern Med 163:1913-21. 2003
  2. ncbi The effect of low molecular weight heparin on survival in patients with advanced malignancy
    Clara P W Klerk
    Department of Vascular Medicine, Academic Medical Center F4 139, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Clin Oncol 23:2130-5. 2005
  3. ncbi Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung
    Tatjana M H Niers
    Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
    Clin Exp Metastasis 26:171-8. 2009
  4. ncbi Antithrombotic therapy and cancer
    Marcello Di Nisio
    Department of Vascular Medicine and of Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Curr Opin Hematol 11:187-91. 2004
  5. ncbi Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals
    Clara P W Klerk
    Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Biotechniques 43:7-13, 30. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review
    Clara P W Klerk
    Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Arch Intern Med 163:1913-21. 2003
    ..Central venous catheters (CVCs) are used in a wide variety of patients. Associated complications are thrombosis and infection. It is a matter of debate whether thromboprophylaxis is beneficial...
  2. ncbi The effect of low molecular weight heparin on survival in patients with advanced malignancy
    Clara P W Klerk
    Department of Vascular Medicine, Academic Medical Center F4 139, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    J Clin Oncol 23:2130-5. 2005
    ..In a double-blind study, we evaluated the effect of low molecular weight heparin on survival in patients with advanced malignancy without venous thromboembolism...
  3. ncbi Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung
    Tatjana M H Niers
    Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
    Clin Exp Metastasis 26:171-8. 2009
    ..Fibrin content of the tumors was not affected by LMWH. It is concluded that effects of anticoagulants are dependent on cancer cell type and are correlated with their CD24 and PAR-1 expression...
  4. ncbi Antithrombotic therapy and cancer
    Marcello Di Nisio
    Department of Vascular Medicine and of Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Curr Opin Hematol 11:187-91. 2004
    ..To assess the current evidence from recent clinical trials investigating antithrombotic agents for the prophylaxis and treatment of venous thromboembolism in cancer patients and for the effects of these agents on cancer progression...
  5. ncbi Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals
    Clara P W Klerk
    Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Biotechniques 43:7-13, 30. 2007
    ....